Terms: = Leukemia AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Diagnosis
18 results:
1. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
2. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
[TBL] [Abstract] [Full Text] [Related]
3. Second Primary Cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
[TBL] [Abstract] [Full Text] [Related]
4. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
5. Outcomes of Patients With Acute Myeloid leukemia Who Relapse After 5 Years of Complete Remission.
Patel A; Agha M; Raptis A; Hou JZ; Farah R; Redner RL; Im A; Dorritie KA; Sehgal A; Rossetti J; Saul M; Normolle D; Lontos K; Boyiadzis M
Oncol Res; 2021 Sep; 28(7):811-814. PubMed ID: 32753091
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract] [Full Text] [Related]
7. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
[TBL] [Abstract] [Full Text] [Related]
8. A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells.
Collin JF; Wells JW; Czepulkowski B; Lyne L; Duriez PJ; Banham AH; Mufti GJ; Guinn BA
Genes Chromosomes Cancer; 2015 May; 54(5):288-302. PubMed ID: 25706801
[TBL] [Abstract] [Full Text] [Related]
9. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
Lee-Sherick AB; Eisenman KM; Sather S; McGranahan A; Armistead PM; McGary CS; Hunsucker SA; Schlegel J; Martinson H; Cannon C; Keating AK; Earp HS; Liang X; DeRyckere D; Graham DK
Oncogene; 2013 Nov; 32(46):5359-68. PubMed ID: 23474756
[TBL] [Abstract] [Full Text] [Related]
10. FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.
Daver N; Strati P; Jabbour E; Kadia T; Luthra R; Wang S; Patel K; Ravandi F; Cortes J; Qin Dong X; Kantarjian H; Garcia-Manero G
Am J Hematol; 2013 Jan; 88(1):56-9. PubMed ID: 23115106
[TBL] [Abstract] [Full Text] [Related]
11. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study.
Pearce MS; Salotti JA; Little MP; McHugh K; Lee C; Kim KP; Howe NL; Ronckers CM; Rajaraman P; Sir Craft AW; Parker L; Berrington de González A
Lancet; 2012 Aug; 380(9840):499-505. PubMed ID: 22681860
[TBL] [Abstract] [Full Text] [Related]
12. [Expression of CYR61, CTGF, VEGF-C, VEGFR-2 mRNA in bone marrow of leukemia patients and its clinical significance].
Xu N; He QT; Lu Y; Han XM; Ma HJ; Zhang DX; Liu XW; Yuan XJ; Jia GR; Li J; Li Z; Li ZQ; Han HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1368-73. PubMed ID: 22169285
[TBL] [Abstract] [Full Text] [Related]
13. Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.
Behrendt CE; Rosenthal J; Bolotin E; Nakamura R; Zaia J; Forman SJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):54-60. PubMed ID: 19135943
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.
Jantunen E; Ruutu P; Niskanen L; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T
Bone Marrow Transplant; 1997 Apr; 19(8):801-8. PubMed ID: 9134172
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disorders.
Batata A; Shen B
Am J Hematol; 1993 Aug; 43(4):265-70. PubMed ID: 8372808
[TBL] [Abstract] [Full Text] [Related]
16. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).
Leuk Res; 1991; 15(2-3):81-90. PubMed ID: 2016910
[TBL] [Abstract] [Full Text] [Related]
17. Incidence of childhood leukemia in Sweden 1975-1980.
Gustafsson G; Kreuger A
Acta Paediatr Scand; 1982 Nov; 71(6):887-92. PubMed ID: 6961729
[TBL] [Abstract] [Full Text] [Related]
18. leukemia among participants in military maneuvers at a nuclear bomb test. A preliminary report.
Caldwell GG; Kelley DB; Heath CW
JAMA; 1980 Oct; 244(14):1575-8. PubMed ID: 6932516
[TBL] [Abstract] [Full Text] [Related]
